LVM Capital Management Ltd. MI Has $381,000 Stock Holdings in The Clorox Company $CLX

LVM Capital Management Ltd. MI trimmed its stake in The Clorox Company (NYSE:CLX) by 2.9% in the second quarter, HoldingsChannel reports. The firm owned 3,171 shares of the company’s stock after selling 95 shares during the period. LVM Capital Management Ltd. MI’s holdings in Clorox were worth $381,000 as of its most recent SEC filing.

A number of other large investors have also bought and sold shares of CLX. Wood Tarver Financial Group LLC acquired a new stake in Clorox in the fourth quarter worth $31,000. Ransom Advisory Ltd acquired a new stake in Clorox in the first quarter worth $35,000. GW&K Investment Management LLC grew its holdings in Clorox by 239.1% in the first quarter. GW&K Investment Management LLC now owns 295 shares of the company’s stock worth $43,000 after purchasing an additional 208 shares during the period. Roble Belko & Company Inc grew its holdings in Clorox by 140.7% in the first quarter. Roble Belko & Company Inc now owns 361 shares of the company’s stock worth $53,000 after purchasing an additional 211 shares during the period. Finally, IMA Advisory Services Inc. acquired a new stake in Clorox in the first quarter worth $58,000. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Clorox Stock Down 0.5%

CLX opened at $123.75 on Friday. The company has a debt-to-equity ratio of 5.15, a current ratio of 0.84 and a quick ratio of 0.57. The company’s 50-day moving average is $124.27 and its 200 day moving average is $132.44. The Clorox Company has a fifty-two week low of $116.53 and a fifty-two week high of $171.37. The firm has a market capitalization of $15.14 billion, a P/E ratio of 18.98, a PEG ratio of 1.00 and a beta of 0.52.

Clorox (NYSE:CLX) last released its quarterly earnings results on Thursday, July 31st. The company reported $2.87 earnings per share for the quarter, beating analysts’ consensus estimates of $2.24 by $0.63. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The company had revenue of $1.99 billion for the quarter, compared to analyst estimates of $1.94 billion. During the same period last year, the firm earned $1.82 earnings per share. The firm’s revenue was up 4.5% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. Research analysts expect that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, August 29th. Investors of record on Wednesday, August 13th were given a dividend of $1.24 per share. The ex-dividend date of this dividend was Wednesday, August 13th. This is an increase from Clorox’s previous quarterly dividend of $1.22. This represents a $4.96 dividend on an annualized basis and a dividend yield of 4.0%. Clorox’s payout ratio is 76.07%.

Insider Buying and Selling at Clorox

In related news, COO Eric H. Reynolds sold 15,041 shares of the firm’s stock in a transaction dated Thursday, September 4th. The shares were sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the transaction, the chief operating officer directly owned 54,221 shares of the company’s stock, valued at $6,711,475.38. This trade represents a 21.72% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.57% of the stock is owned by insiders.

Analyst Ratings Changes

CLX has been the subject of a number of analyst reports. Citigroup reiterated a “neutral” rating and set a $135.00 price objective (down from $140.00) on shares of Clorox in a report on Tuesday, July 15th. JPMorgan Chase & Co. lifted their price objective on shares of Clorox from $133.00 to $135.00 and gave the company a “neutral” rating in a report on Monday, September 8th. Barclays reduced their price objective on shares of Clorox from $129.00 to $119.00 and set an “underweight” rating for the company in a report on Tuesday, July 15th. Morgan Stanley reduced their price objective on shares of Clorox from $150.00 to $137.00 and set an “equal weight” rating for the company in a report on Friday, August 1st. Finally, Wells Fargo & Company reduced their price objective on shares of Clorox from $138.00 to $130.00 and set an “equal weight” rating for the company in a report on Friday, September 5th. One analyst has rated the stock with a Buy rating, eight have issued a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Reduce” and a consensus target price of $142.18.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.